MacroGenics Correlations

MGNX Stock  USD 1.69  0.03  1.74%   
The current 90-days correlation between MacroGenics and Ovid Therapeutics is 0.11 (i.e., Average diversification). The correlation of MacroGenics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

MacroGenics Correlation With Market

Poor diversification

The correlation between MacroGenics and DJI is 0.77 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding MacroGenics and DJI in the same portfolio, assuming nothing else is changed.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MacroGenics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy MacroGenics Stock please use our How to Invest in MacroGenics guide.

Moving together with MacroGenics Stock

  0.7ENGN enGene Holdings CommonPairCorr
  0.6363E ONWARD MEDICAL BVPairCorr
  0.77IMMP Immutep Ltd ADRPairCorr
  0.75MRKR Marker TherapeuticsPairCorr
  0.72ANNX AnnexonPairCorr
  0.71AVCR Avricore HealthPairCorr
  0.66BOLT Bolt BiotherapeuticsPairCorr
  0.69TNGX Tango TherapeuticsPairCorr

Moving against MacroGenics Stock

  0.9DWTX Dogwood TherapeuticsPairCorr
  0.84ABP Abpro HoldingsPairCorr
  0.81GNLX Genelux CommonPairCorr
  0.8KURA Kura OncologyPairCorr
  0.77LYRA Lyra TherapeuticsPairCorr
  0.74EDIT Editas Medicine Earnings Call This WeekPairCorr
  0.69IMRN Immuron Ltd ADRPairCorr
  0.6QSI QuantumSiPairCorr
  0.35EVGN EvogenePairCorr
  0.32LRMR Larimar TherapeuticsPairCorr
  0.83MREO Mereo BioPharma GroupPairCorr
  0.75ACXP Acurx Pharmaceuticals LLCPairCorr
  0.74PRQR ProQR Therapeutics Earnings Call This WeekPairCorr
  0.65MBIO Mustang BioPairCorr
  0.54AURA Aura BiosciencesPairCorr
  0.4PROK ProKidney CorpPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ORMPWHWK
STTKWHWK
ORMPSTTK
ZNTLSTTK
ZNTLORMP
IFRXCLNN
  

High negative correlations

WHWKCLNN
COYAZNTL
COYAORMP
STTKCLNN
COYASTTK
ORMPCLNN

Risk-Adjusted Indicators

There is a big difference between MacroGenics Stock performing well and MacroGenics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze MacroGenics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
OVID  4.27  0.46  0.07  2.14  4.85 
 9.70 
 36.13 
CNTX  4.29  1.39  0.29 (30.91) 3.56 
 9.59 
 24.11 
CLNN  5.04 (1.16) 0.00 (0.46) 0.00 
 9.44 
 38.74 
WHWK  3.25  0.42  0.12  0.48  3.31 
 6.98 
 21.49 
STTK  3.62  1.13  0.30  4.76  3.13 
 6.42 
 27.88 
CNTB  4.71  1.07  0.17 (0.58) 4.38 
 11.93 
 38.27 
ORMP  2.78  0.56  0.24  0.36  2.05 
 6.98 
 17.67 
ZNTL  5.13  1.07  0.22  0.61  4.49 
 17.36 
 49.29 
COYA  2.66 (0.23) 0.00 (0.34) 0.00 
 5.28 
 18.45 
IFRX  4.63 (0.55) 0.00 (0.14) 0.00 
 7.84 
 43.11 

MacroGenics Corporate Management

Eric RisserSr. VP of Bus. Devel. and Portfolio ManagementProfile
Beth SmithController VPProfile
Steve HarigSenior ResourcesProfile
Christopher MDVP CommunicationsProfile
Harish KrishnaswamySenior PlanningProfile
Ezio MDSenior OfficerProfile